China Tian Yuan Healthcare Group Ltd

The company maintains a debt-to-equity ratio of 0.24, indicating a relatively conservative capital structure with a moderate reliance on debt financing. Its liquidity position is assessed as medium, with cash and equivalents amounting to 27.73 million HKD, partially offset by long-term debt of 38.72 million HKD. This results in a net cash position that is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics are not explicitly provided, but the company's revenue of 191.78 million HKD suggests a modest scale of operations. Given the industry's preferred metrics, a more detailed analysis of operating margins and return on invested capital would be necessary to fully assess its performance relative to the cohort median. The company's revenue is distributed across four segments: Healthcare, Money Lending and Related Business, Investment Holding, and Hospitality. However, the disclosed data does not specify the revenue contribution of each segment, making it difficult to assess geographic or segment concentration. The company's growth trajectory is not clearly defined in the available data. Analyst estimates for the most recent actual revenue and EPS are 65.27 million HKD and 0.13 HKD, respectively, but no forward-looking guidance is provided to assess future performance. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could impact its ability to meet short-term obligations. No significant dilution sources are identified, and the company has not made recent equity issuances that would suggest near-term dilution pressure. Recent events and filings are not detailed in the provided data, so no specific recent developments can be reported. The company's financial disclosures and regulatory filings would need to be reviewed for any material changes or strategic initiatives.